EconPapers    
Economics at your fingertips  
 

Printing of small molecular medicines from the vapor phase

Olga Shalev, Shreya Raghavan, J. Maxwell Mazzara, Nancy Senabulya, Patrick D. Sinko, Elyse Fleck, Christopher Rockwell, Nicholas Simopoulos, Christina M. Jones, Anna Schwendeman, Geeta Mehta, Roy Clarke, Gregory E. Amidon and Max Shtein ()
Additional contact information
Olga Shalev: University of Michigan
Shreya Raghavan: University of Michigan
J. Maxwell Mazzara: University of Michigan
Nancy Senabulya: University of Michigan
Patrick D. Sinko: University of Michigan
Elyse Fleck: University of Michigan
Christopher Rockwell: University of Michigan
Nicholas Simopoulos: University of Michigan
Christina M. Jones: University of Michigan
Anna Schwendeman: University of Michigan
Geeta Mehta: University of Michigan
Roy Clarke: University of Michigan
Gregory E. Amidon: University of Michigan
Max Shtein: University of Michigan

Nature Communications, 2017, vol. 8, issue 1, 1-9

Abstract: Abstract There is growing need to develop efficient methods for early-stage drug discovery, continuous manufacturing of drug delivery vehicles, and ultra-precise dosing of high potency drugs. Here we demonstrate the use of solvent-free organic vapor jet printing to deposit nanostructured films of small molecular pharmaceutical ingredients, including caffeine, paracetamol, ibuprofen, tamoxifen, BAY 11-7082 and fluorescein, with accuracy on the scale of micrograms per square centimeter, onto glass, Tegaderm, Listerine tabs, and stainless steel microneedles. The printed films exhibit similar crystallographic order and chemistry as the original powders; controlled, order-of-magnitude enhancements of dissolution rate are observed relative to powder-form particles. In vitro treatment of breast and ovarian cancer cell cultures in aqueous media by tamoxifen and BAY 11-7082 films shows similar behavior to drugs pre-dissolved in dimethyl sulfoxide. The demonstrated precise printing of medicines as films, without the use of solvents, can accelerate drug screening and enable continuous manufacturing, while enhancing dosage accuracy.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-017-00763-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00763-6

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-017-00763-6

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00763-6